Open data and health issues: what we cannot know in France

Despite having a huge data base France's state illness insurance forbids statistical studies on these data. Contrary to the point of view of the french bureaucracy this secrecy  do not protect individuals from misuse of these data by private businesses. It only impairs research and development of better treatments.
But that is not the only issue raised by the retention of data.
Some others issues are critical as appears in this week in Drug and alcohol dependence a journal devoted to publish papers on drugs alcohol and tobacco use.
Drug overdose is increasing in NYC.
What happens in Europe and France?

Prescription opioid mortality trends in New York City, 1990–2006: Examining the emergence of an epidemic ^☆

• Magdalena Cerdá^a, , , , 
• Yusuf Ransome^b, 
• Katherine M. Keyes^a, 
• Karestan C. Koenen^a,
• Melissa Tracy^a, 
• Kenneth J. Tardiff^c, 
• David Vlahov^d, 
• Sandro Galea^a

In order to have a look to open data in health within the hexagone:

http://www.data.gouv.fr/content/search?SearchText=Financement+et+d%C3%A9penses+de+la+s%C3%A9curit%C3%A9+sociale


http://www.medpagetoday.com/MeetingCoverage/ENDO/39963?xid=nl_mpt_DHE_2013-06-20&utm_content=&utm_medium=email&utm_campaign=DailyHeadlines&utm_source=WC&eun=g432148d0r&userid=432148&email=guyandrepelouze@gmail.com&mu_id=5529932